Align Technology | ALGN - Current Assets


Align Technology reported $2.62B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
3M USD 16.39B 298M Dec/2025
Align Technology USD 2.62B 82.47M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Bruker USD 2.21B 138.1M Dec/2025
Cardinal Health USD 39.23B 693M Dec/2025
Charles River Laboratories USD 1.45B 85.06M Dec/2025
Cooper Companies USD 2.13B 27.4M Dec/2025
CVS Health USD 74.71B 2.4B Dec/2025
Danaher USD 12.76B 3.15B Dec/2025
Dentsply International USD 2.02B 49M Dec/2025
Dexcom USD 4.03B 1.19B Dec/2025
Henry Schein USD 4.46B 69M Dec/2025
Idexx Laboratories USD 1.41B 63.23M Dec/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Masimo USD 926M 122.3M Dec/2025
McKesson USD 59.7B 190M Dec/2025
Mettler Toledo International USD 1.36B 81.46M Dec/2025
Revvity USD 2.24B 95.96M Dec/2025
Solventum Corp USD 3.86B 548M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Veeva Systems USD 8B 885.78M Dec/2025
Waters USD 1.99B 69.86M Dec/2025
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025
Zoetis USD 6.77B 185M Dec/2025